NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/28/2024
Back to search
Official data from USPTO
GAMMABODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GAMMABODY
ST13
US500000079328719Class
1, 5, 42, 44
Filing
79328719
Registration
6970395
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
09/28/2024
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
07/26/2021
Registration date
02/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/07/2023
Last transaction
02/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
32
Owner location
NL
Examiner
MASON, JARED MICHAEL
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Lava Therapeutics N.V.
Representatives
Robert R. Baron, Jr. Ballard Spahr LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Antibodies for scientific and research use; proteinsenzymeschemical and biochemical preparations and substances for use in the manufacture of medicines
Class 5
Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy productspharmaceutical preparations for the treatment of cancerautoimmune diseasesimmunological disorders; biological preparations for the treatment of cancerautoimmune diseasesimmunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment or diagnosis of cancerautoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposesfor treatment or diagnosis of cancerautoimmune diseases and immunological disorders
Class 42
Bio-technology and scientific servicesscientific and medical research relating to bio-technology and scienceantibodiesproteins and enzymes; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research servicesscientific and medical research in the fields of antibodiesprotein and enzyme evolving services; biochemistry research servicesscientific and medical research in the fields of antibodiesprotein and enzyme cataloging and library services
Class 44
Providing health information about the treatment or diagnosis of cancerautoimmune diseases and immunological disorders via a website
Publications
History of USPTO decisions and trademark events.
35 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/09/2023
FIMP
FINAL DISPOSITION PROCESSED
05/09/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/09/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2022
PUBO
PUBLISHED FOR OPPOSITION
11/22/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/18/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/18/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/18/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/20/2022
RFNT
REFUSAL PROCESSED BY IB
06/22/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/26/2022
RFRR
REFUSAL PROCESSED BY MPU
05/26/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/23/2022
CNRT
NON-FINAL ACTION WRITTEN
04/22/2022
DOCK
ASSIGNED TO EXAMINER
04/21/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/04/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/26/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/19/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/19/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/19/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/19/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/19/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/22/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/18/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/16/2021
Continuous trademark protection
Get notified about every new filing that threatens GAMMABODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.